{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:42:01Z","timestamp":1792456921006,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To characterize the burden, temporal trends, geographic heterogeneity, demographic components, pandemic-era deviations, and projected age-standardized rates of bladder cancer across Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an ecological secondary analysis of modeled Global Burden of Disease Study 2023 estimates for the GBD aggregate labeled \u201cAfrican Union\u201d and 54 African country locations from 2010 to 2023. Incidence, prevalence, deaths, and disability-adjusted life-years (DALYs) were assessed as counts and age-standardized rates (ASRs) per 100,000 population for both sexes combined. Trends were summarized using estimated annual percentage changes. Incidence trajectories were descriptively grouped using dynamic time warping, and changes in counts were partitioned into population-size, age-structure, and age-specific rate components using Das Gupta decomposition. Exploratory autoregressive integrated moving average models compared GBD-estimated rates in 2020\u20132023 with trajectories extrapolated from 2010 to 2019. Country-specific ASRs were projected through 2030 using log-linear models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For the GBD aggregate labeled \u201cAfrican Union,\u201d incident cases increased from 16,357 in 2010 to 31,503 in 2023, prevalent cases from 73,806 to 147,599, deaths from 9,261 to 16,467, and DALYs from 232,414 to 415,746. Corresponding ASRs increased from 3.5 to 4.4 for incidence, 13.9 to 18.3 for prevalence, 2.2 to 2.6 for deaths, and 48.1 to 56.1 for DALYs. The highest estimated incidence ASRs in 2023 occurred in Tunisia, Malawi, Libya, Egypt, and Mali, while several countries with low estimated baseline rates had rapid relative increases. Population-size change was the largest decomposition component, accounting for 39.8%\u201358.8% of the increase across outcomes, with additional contributions from age structure and age-specific rates. GBD-estimated incidence, mortality, and DALY rates during 2020\u20132023 were above the extrapolated point forecasts; however, this exploratory analysis did not establish a causal pandemic effect. The primary projection models yielded higher fitted 2030 ASRs in a majority of countries, although results varied across training windows.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GBD 2023 estimates indicate an increasing but geographically heterogeneous bladder cancer burden across Africa. Population growth was the largest contributor to increasing counts, while age-structure and age-specific rate changes also contributed. Regionally tailored prevention, diagnostic and treatment capacity, and improved cancer surveillance are needed. Pandemic-era deviations and 2030 projections should be interpreted as model-dependent rather than causal or definitive forecasts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13027-026-00782-3","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:45:11Z","timestamp":1784821511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bladder cancer in Africa, 2010\u20132023: burden, geographic heterogeneity, demographic drivers, pandemic-era temporal changes, and projections to 2030"],"prefix":"10.1186","volume":"21","author":[{"given":"Yongli","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"782_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Filho AM, Laversanne M, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clinicians. 2026;76(4):e70090. https:\/\/doi.org\/10.3322\/caac.70090.","DOI":"10.3322\/caac.70090"},{"issue":"5","key":"782_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.eururo.2025.12.011","volume":"89","author":"AM Filho","year":"2026","unstructured":"Filho AM, Briganti A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urology. 2026;89(5):426\u201336. https:\/\/doi.org\/10.1016\/j.eururo.2025.12.011.","journal-title":"Eur Urology"},{"issue":"5","key":"782_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20(5):287\u2013304. https:\/\/doi.org\/10.1038\/s41571-023-00744-3.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"782_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, Black PC, Comp\u00e9rat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urology. 2023;84(2):176\u201390. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.029.","journal-title":"Eur Urology"},{"issue":"1","key":"782_CR5","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1186\/s12889-025-25144-3","volume":"25","author":"OS Ilesanmi","year":"2025","unstructured":"Ilesanmi OS, Afolabi AA, Afolabi OJ. Trends in smoking tobacco in Africa, 1990\u20132019: analysis from the global burden of disease study 2019. BMC Public Health. 2025;25(1):4077. https:\/\/doi.org\/10.1186\/s12889-025-25144-3.","journal-title":"BMC Public Health"},{"issue":"1","key":"782_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/19338244.2012.719556","volume":"69","author":"S Amr","year":"2014","unstructured":"Amr S, Dawson R, Saleh DA, Magder LS, Mikhail NN, George DMS, et al. Agricultural workers and urinary bladder cancer risk in Egypt. Archives Environ Occup Health. 2014;69(1):3\u201310. https:\/\/doi.org\/10.1080\/19338244.2012.719556.","journal-title":"Archives Environ Occup Health"},{"issue":"2","key":"782_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/tropicalmed10020042","volume":"10","author":"D Peng","year":"2025","unstructured":"Peng D, Zhu Y, Liu L, Zhang J, Huang P, Bai S, et al. Schistosomiasis burden and trend analysis in Africa: insights from the global burden of disease study 2021. TropicalMed. 2025;10(2):42. https:\/\/doi.org\/10.3390\/tropicalmed10020042.","journal-title":"TropicalMed"},{"issue":"2","key":"782_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/jcm10020205","volume":"10","author":"LL Santos","year":"2021","unstructured":"Santos LL, Santos J, Gouveia MJ, Bernardo C, Lopes C, Rinaldi G, et al. Urogenital schistosomiasis\u2014history, pathogenesis, and bladder cancer. JCM. 2021;10(2):205. https:\/\/doi.org\/10.3390\/jcm10020205.","journal-title":"JCM"},{"issue":"1","key":"782_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13027-023-00491-1","volume":"18","author":"C Yohana","year":"2023","unstructured":"Yohana C, Bakuza JS, Kinung\u2019hi SM, Nyundo BA, Rambau PF. The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period. Infect Agents Cancer. 2023;18(1):10. https:\/\/doi.org\/10.1186\/s13027-023-00491-1.","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"782_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/iju.13824","volume":"26","author":"D Adeloye","year":"2019","unstructured":"Adeloye D, Harhay MO, Ayepola OO, Santos JPD, David RA, Ogunlana OO, et al. Estimate of the incidence of bladder cancer in Africa: a systematic review and Bayesian meta-analysis. Int J Urology. 2019;26(1):102\u201312. https:\/\/doi.org\/10.1111\/iju.13824.","journal-title":"Int J Urology"},{"issue":"6","key":"782_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(22)00270-4","volume":"23","author":"F Bray","year":"2022","unstructured":"Bray F, Parkin DM, Gnangnon F, Tshisimogo G, Peko J-F, Adoubi I, et al. Cancer in sub-saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. The Lancet Oncol. 2022;23(6):719\u201328. https:\/\/doi.org\/10.1016\/S1470-2045(22)00270-4.","journal-title":"The Lancet Oncol"},{"key":"782_CR12","doi-asserted-by":"publisher","first-page":"1050168","DOI":"10.3389\/fonc.2022.1050168","volume":"12","author":"Z Abdul-Sater","year":"2022","unstructured":"Abdul-Sater Z, Mukherji D, Adib SM, Shamseddine A, Abu-Sitta G, Fadhil I, et al. Cancer registration in the Middle East, North Africa, and Turkey (MENAT) region: a tale of conflict, challenges, and opportunities. Front Oncol. 2022;12:1050168. https:\/\/doi.org\/10.3389\/fonc.2022.1050168.","journal-title":"Front Oncol"},{"key":"782_CR13","doi-asserted-by":"publisher","first-page":"06048","DOI":"10.7189\/jogh.13.06048","volume":"13","author":"S Rine","year":"2023","unstructured":"Rine S, Lara ST, Bikomeye JC, Beltr\u00e1n-Ponce S, Kibudde S, Niyonzima N, et al. The impact of the COVID-19 pandemic on cancer care including innovations implemented in Sub-Saharan Africa: a systematic review. J Glob Health. 2023;13:06048. https:\/\/doi.org\/10.7189\/jogh.13.06048.","journal-title":"J Glob Health"},{"issue":"10512","key":"782_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","volume":"406","author":"LM Force","year":"2025","unstructured":"Force LM, Kocarnik JM, May ML, Bhangdia K, Crist A, Penberthy L, et al. The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the global burden of disease study 2023. Lancet. 2025;406(10512):1565\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(25)01635-6.","journal-title":"Lancet"},{"issue":"29","key":"782_CR15","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28(29):3670\u201382. https:\/\/doi.org\/10.1002\/sim.3733.","journal-title":"Stat Med"},{"issue":"6","key":"782_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, et al. Epidemiology, screening, and prevention of bladder cancer. Eur Urology Oncol. 2022;5(6):628\u201339. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003.","journal-title":"Eur Urology Oncol"},{"issue":"1","key":"782_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s43046-020-00055-z","volume":"32","author":"MS Zaghloul","year":"2020","unstructured":"Zaghloul MS, Zaghloul TM, Bishr MK, Baumann BC. Urinary schistosomiasis and the associated bladder cancer: update. J Egypt Natl Canc Inst. 2020;32(1):44. https:\/\/doi.org\/10.1186\/s43046-020-00055-z.","journal-title":"J Egypt Natl Canc Inst"},{"key":"782_CR18","doi-asserted-by":"publisher","first-page":"1667873","DOI":"10.3389\/fpubh.2025.1667873","volume":"13","author":"C Mandanach","year":"2025","unstructured":"Mandanach C, Handra CM, Rascu A, Hohor S, Gurzu IL, Otelea MR, et al. Occupational hazards and bladder cancer\u2014an umbrella review of the risk in workers exposed over the past 30 years. Front Public Health. 2025;13:1667873. https:\/\/doi.org\/10.3389\/fpubh.2025.1667873.","journal-title":"Front Public Health"},{"issue":"1","key":"782_CR19","doi-asserted-by":"publisher","first-page":"205427042312178","DOI":"10.1177\/20542704231217888","volume":"15","author":"E Ayubi","year":"2024","unstructured":"Ayubi E, Lyus R, Brhlikova P, Pollock AM. A critical appraisal of the quality of data submitted by sub-Saharan African cancer registries to GLOBOCAN 2020. JRSM Open. 2024;15(1):20542704231217888. https:\/\/doi.org\/10.1177\/20542704231217888.","journal-title":"JRSM Open"},{"issue":"1","key":"782_CR20","doi-asserted-by":"publisher","first-page":"1811476","DOI":"10.1080\/16549716.2020.1811476","volume":"13","author":"OA Makinde","year":"2020","unstructured":"Makinde OA, Odimegwu CO, Udoh MO, Adedini SA, Akinyemi JO, Atobatele A, et al. Death registration in Nigeria: a systematic literature review of its performance and challenges. Global Health Action. 2020;13(1):1811476. https:\/\/doi.org\/10.1080\/16549716.2020.1811476.","journal-title":"Global Health Action"},{"issue":"1","key":"782_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42506-020-00040-3","volume":"95","author":"N Lotfy","year":"2020","unstructured":"Lotfy N. Spatial analysis of completeness of death registration in Egypt. J Egypt Public Health Assoc. 2020;95(1):12. https:\/\/doi.org\/10.1186\/s42506-020-00040-3.","journal-title":"J Egypt Public Health Assoc"},{"key":"782_CR22","doi-asserted-by":"publisher","unstructured":"Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI, et al. Cancer in sub-saharan Africa: a lancet oncology commission. The Lancet Oncol. 2022;23(6):e251\u2013312. https:\/\/doi.org\/10.1016\/S1470-2045(21)00720-8.","DOI":"10.1016\/S1470-2045(21)00720-8"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00782-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00782-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-026-00782-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:37:26Z","timestamp":1792456646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-026-00782-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1186\/s13027-026-00782-3","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used publicly available, aggregated, and de-identified data from the Global Burden of Disease Study 2023. No individual-level or identifiable participant data were used. Therefore, ethics approval and informed consent were not required.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"69"}}